Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 27.2.2023 | EN | Official Journal of the European Union | C 71/27 |

---

Order of the General Court of 15 December 2022 — MiMedx Group v EUIPO — DIZG (Epiflex)

(Case T-706/20) [(1)](#ntr1-C_2023071EN.01002702-E0001)

(EU trade mark - Revocation proceedings - Withdrawal of the application for revocation - No need to adjudicate)

(2023/C 71/36)

Language of the case: German

Parties

Applicant: MiMedx Group, Inc. (Marietta, Georgia, United States) (represented by: J. Bogatz and Y. Stone, lawyers)

Defendant: European Union Intellectual Property Office (represented by: A. Bosse and E. Markakis, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO intervening before the General Court: DIZG Deutsches Institut für Zell- und Gewebeersatz gGmbH (Berlin, Germany) (represented by: M. Plesser and R. Heine, lawyers)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 25 September 2020 (Case R 133/2020-2).

Operative part of the order

|  |  |
| --- | --- |
| 1. | There is no longer any need to adjudicate on the action. |

|  |  |
| --- | --- |
| 2. | MiMedx Group, Inc. and DIZG Deutsches Institut für Zell- und Gewebeersatz gGmbH shall bear their own costs and each pay half of those incurred by the European Union Intellectual Property Office (EUIPO). |

---

---

[Top](#document1)